US6482516B1
(en)
*
|
1993-07-20 |
2002-11-19 |
Banner Pharmacaps, Inc. |
Enrobed tablet
|
US6395303B1
(en)
|
1996-06-10 |
2002-05-28 |
Edward Mendell Co., Inc. |
Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
|
US5585115A
(en)
*
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
US6936277B2
(en)
*
|
1995-01-09 |
2005-08-30 |
J. Rettenmaier & Soehne Gmbh & Co. Kg |
Pharmaceutical excipient having improved compressibility
|
US6471994B1
(en)
*
|
1995-01-09 |
2002-10-29 |
Edward Mendell Co., Inc. |
Pharmaceutical excipient having improved compressibility
|
US5948438A
(en)
*
|
1995-01-09 |
1999-09-07 |
Edward Mendell Co., Inc. |
Pharmaceutical formulations having improved disintegration and/or absorptivity
|
US6106865A
(en)
*
|
1995-01-09 |
2000-08-22 |
Edward Mendell Co., Inc. |
Pharmaceutical excipient having improved compressibility
|
FR2736550B1
(fr)
*
|
1995-07-14 |
1998-07-24 |
Sandoz Sa |
Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
|
US6391337B2
(en)
|
1995-11-15 |
2002-05-21 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
US6852336B2
(en)
|
1995-11-15 |
2005-02-08 |
J. Rettenmaier & Soehne Gmbh + Co. Kg |
Directly compressible high load acetaminophen formulations
|
US5733578A
(en)
*
|
1995-11-15 |
1998-03-31 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
JP4064476B2
(ja)
*
|
1996-03-29 |
2008-03-19 |
エラワン ファーマスーティカル リサーチ アンドラボラトリー カンパニー リミテッド |
二酸化珪素を有する球状凝集した澱粉
|
ATE229566T1
(de)
*
|
1996-05-14 |
2002-12-15 |
Procter & Gamble |
Verfahren zur herstellung eines waschmittels mit niedrigem schüttgewicht durch agglomeration und anschliessender dielektrischer erwärmung
|
US5989591A
(en)
*
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
FR2761266B1
(fr)
*
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
FI109088B
(fi)
*
|
1997-09-19 |
2002-05-31 |
Leiras Oy |
Tabletti ja menetelmä sen valmistamiseksi
|
FR2769854B1
(fr)
*
|
1997-10-21 |
2000-03-31 |
Prographarm Lab |
Nouveau procede d'obtention de microspheres et les produits ainsi realises
|
CA2300452C
(en)
*
|
1997-12-22 |
2000-11-28 |
Schering Corporation |
Orally administrable solid ribavirin dosage forms and process for making them
|
US6232351B1
(en)
*
|
1998-05-22 |
2001-05-15 |
Amway Corporation |
Co-processed botanical plant composition
|
EP1083885B1
(de)
*
|
1998-06-11 |
2006-12-27 |
Pharmacia & Upjohn Company LLC |
Delavirdin tablettenformulierung
|
IT1301969B1
(it)
*
|
1998-07-30 |
2000-07-20 |
Lisapharma Spa |
Sucralfato gel secco granulare e poroso procedimento per la suapreparazione, e composizioni farmaceutiche solide che lo contengono
|
US20020009478A1
(en)
*
|
1998-08-24 |
2002-01-24 |
Douglas Joseph Dobrozsi |
Oral liquid mucoadhesive compositions
|
SA99191255B1
(ar)
|
1998-11-30 |
2006-11-25 |
جي دي سيرل اند كو |
مركبات سيليكوكسيب celecoxib
|
US6465502B1
(en)
*
|
1998-12-23 |
2002-10-15 |
Novartis Ag |
Additional therapeutic use
|
US20030026835A1
(en)
*
|
1999-02-15 |
2003-02-06 |
Sumitomo Pharmaceuticals Company Limited |
Tablets disintegrating rapidly in the oral cavity
|
US20040258750A1
(en)
*
|
1999-06-28 |
2004-12-23 |
Gerard Alaux |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
EP1064938A1
(de)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Pharmazeutische Dosierungsformen zur kontrollierte Wirkstoffabgabe mit mindenstens ein pulsierendem Zeitverlauf
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US6294198B1
(en)
|
1999-08-24 |
2001-09-25 |
Purepac Pharmaceutical Co. |
Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
|
US6656501B1
(en)
|
1999-09-01 |
2003-12-02 |
John T. Cooker |
Oral delivery system and method for making same
|
US20040101540A1
(en)
*
|
1999-09-01 |
2004-05-27 |
John Cooker |
Oral delivery system and method for making same
|
WO2001022939A1
(en)
|
1999-09-29 |
2001-04-05 |
Fmc Corporation |
Hydrolyzed cellulose granulations of salts of drugs
|
GB9924351D0
(en)
|
1999-10-14 |
1999-12-15 |
Brennan Frank |
Immunomodulation methods and compositions
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
ES2374717T3
(es)
|
1999-10-29 |
2012-02-21 |
Euro-Celtique S.A. |
Formulaciones de hidrocodona de liberación controlada.
|
CA2393231A1
(en)
|
1999-12-06 |
2001-06-07 |
Edward Mendell Co., Inc. |
Pharmaceutical superdisintegrant
|
US6793934B1
(en)
*
|
1999-12-08 |
2004-09-21 |
Shire Laboratories, Inc. |
Solid oral dosage form
|
US6632429B1
(en)
|
1999-12-17 |
2003-10-14 |
Joan M. Fallon |
Methods for treating pervasive development disorders
|
US6399101B1
(en)
|
2000-03-30 |
2002-06-04 |
Mova Pharmaceutical Corp. |
Stable thyroid hormone preparations and method of making same
|
US6800297B2
(en)
*
|
2000-06-15 |
2004-10-05 |
Acusphere, Inc. |
Porous COX-2 inhibitor matrices and methods of manufacture thereof
|
AT414205B
(de)
|
2000-06-20 |
2006-10-15 |
Vis Vitalis Lizenz & Handels |
Verfahren zur herstellung von ungesättigtem fettsäure-trockenkonzentrat
|
JP2002055277A
(ja)
*
|
2000-08-11 |
2002-02-20 |
Nikon Corp |
リレー結像光学系、および該光学系を備えた照明光学装置並びに露光装置
|
US20070053895A1
(en)
|
2000-08-14 |
2007-03-08 |
Fallon Joan M |
Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
|
JP2004512354A
(ja)
|
2000-10-30 |
2004-04-22 |
ユーロ−セルティーク,エス.エイ. |
ヒドロコドン放出制御製剤
|
US8030002B2
(en)
|
2000-11-16 |
2011-10-04 |
Curemark Llc |
Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
|
AT5874U1
(de)
*
|
2000-12-29 |
2003-01-27 |
Bioorg Bv |
Pharmazeutische zubereitungen enthaltend amlodipinmaleat
|
US20030050312A1
(en)
*
|
2001-03-12 |
2003-03-13 |
Hjorth Thyge Borup |
Novel tablets and capsules and a process for its preparation
|
AU2002252364B2
(en)
|
2001-03-13 |
2005-08-25 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
US6761905B2
(en)
|
2001-05-01 |
2004-07-13 |
Wei Ming Pharmaceutical Mfg. Co., Ltd. |
Process for the preparation of direct tabletting formulations and aids
|
DE10126163A1
(de)
*
|
2001-05-30 |
2002-12-05 |
Degussa |
Pharmazeutische Zubereitungen
|
US20030027848A1
(en)
*
|
2001-06-15 |
2003-02-06 |
Anne Billotte |
Stabilized formulations
|
US7101573B2
(en)
*
|
2001-09-28 |
2006-09-05 |
Mcneil-Pcc, Inc. |
Simethicone solid oral dosage form
|
US20040001886A1
(en)
*
|
2001-10-17 |
2004-01-01 |
Dr. Reddy's Laboratories Limited |
Stabilized pharmaceutical formulations containing amlodipine maleate
|
US6933380B2
(en)
|
2001-10-19 |
2005-08-23 |
Yung-Zip Chemical Ind. Co., Ltd. |
Excipients containing low residual solvent and method for producing the same
|
DE10153078A1
(de)
*
|
2001-10-30 |
2003-05-22 |
Degussa |
Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen
|
US7815936B2
(en)
*
|
2001-10-30 |
2010-10-19 |
Evonik Degussa Gmbh |
Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
US6635675B2
(en)
|
2001-11-05 |
2003-10-21 |
Cypress Bioscience, Inc. |
Method of treating chronic fatigue syndrome
|
US6753017B2
(en)
*
|
2001-11-07 |
2004-06-22 |
Jrs Pharma Lp |
Process for preparing dry extracts
|
US6645526B2
(en)
|
2001-11-13 |
2003-11-11 |
Mylan Pharmaceuticals, Inc. |
Storage stable thyroxine active drug formulations and methods for their production
|
US20030099699A1
(en)
|
2001-11-13 |
2003-05-29 |
Hanshew Dwight D. |
Storage stable thyroxine active drug formulations and methods for their production
|
EP1509204A4
(de)
*
|
2001-11-29 |
2005-07-13 |
Rettenmaier & Soehne Gmbh & Co |
Agglomerierte teilchen mit einem wirkstoff, der zusammen mit verkieselter mikrokristalliner cellulose aufbereitet wird
|
US20030206978A1
(en)
*
|
2001-11-29 |
2003-11-06 |
Bob Sherwood |
Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
|
US7179488B2
(en)
*
|
2001-11-29 |
2007-02-20 |
Bob Sherwood |
Process for co-spray drying liquid herbal extracts with dry silicified MCC
|
JP2003238393A
(ja)
*
|
2002-02-15 |
2003-08-27 |
Otsuka Pharmaceut Co Ltd |
施錠性が改善された錠剤及びその製造方法
|
WO2003086343A2
(en)
*
|
2002-04-05 |
2003-10-23 |
Cadila Healthcare Limited |
Fast disintegrating oral dosage forms
|
US6958161B2
(en)
*
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
US8361514B2
(en)
*
|
2002-06-19 |
2013-01-29 |
Nuevas Alternatives Naturales Thermafat, S.A.P.I. de C.V. |
Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
|
US20030235571A1
(en)
*
|
2002-06-19 |
2003-12-25 |
Gabriel Gojon-Romanillos |
Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
|
SI21221A
(sl)
*
|
2002-06-21 |
2003-12-31 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Hitro razpadljive tablete
|
WO2004022220A1
(en)
*
|
2002-09-04 |
2004-03-18 |
Southwest Research Institute |
Microencapsulation of oxygen or water sensitive materials
|
WO2004022601A2
(en)
*
|
2002-09-05 |
2004-03-18 |
J. Rettenmaier & Soehne Gmbh + Co. Kg |
Compositions for industrial applications
|
PT1551372T
(pt)
*
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
Subunidade de sequestração e composições e métodos relacionados
|
US7005514B2
(en)
*
|
2002-10-16 |
2006-02-28 |
International Paper Company |
Process for preparing microcrystalline cellulose
|
DE10250711A1
(de)
*
|
2002-10-31 |
2004-05-19 |
Degussa Ag |
Pharmazeutische und kosmetische Zubereitungen
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
MXPA05005781A
(es)
*
|
2002-11-29 |
2005-12-12 |
Forest Laboratories |
Combinacion de ibuprofeno y oxicodona para alivio de dolor agudo.
|
US20050038063A1
(en)
*
|
2002-11-29 |
2005-02-17 |
Kenneth Newman |
Method of treating acute pain with unitary dosage form comprising ibuprofen and oxycodone
|
US20040265375A1
(en)
*
|
2003-04-16 |
2004-12-30 |
Platteeuw Johannes J. |
Orally disintegrating tablets
|
US7037405B2
(en)
*
|
2003-05-14 |
2006-05-02 |
International Paper Company |
Surface treatment with texturized microcrystalline cellulose microfibrils for improved paper and paper board
|
US7497924B2
(en)
*
|
2003-05-14 |
2009-03-03 |
International Paper Company |
Surface treatment with texturized microcrystalline cellulose microfibrils for improved paper and paper board
|
WO2004114551A1
(ja)
*
|
2003-06-19 |
2004-12-29 |
Fujitsu Limited |
送信電力制御方法及び装置
|
US7364755B2
(en)
*
|
2003-07-07 |
2008-04-29 |
Synthon Ip Inc. |
Modified calcium phosphate excipient
|
AU2004255436B2
(en)
*
|
2003-07-11 |
2006-11-30 |
F. Hoffmann-La Roche Ag |
Saquinavir mesylate oral dosage form
|
US7198653B2
(en)
|
2003-07-31 |
2007-04-03 |
Delavau Llc |
Calcium carbonate granulation
|
US7838029B1
(en)
|
2003-07-31 |
2010-11-23 |
Watson Laboratories, Inc. |
Mirtazapine solid dosage forms
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
AU2004274016B2
(en)
*
|
2003-09-18 |
2010-05-13 |
Children's Medical Center Corporation |
Treatment of severe distal colitis
|
AU2004283832B2
(en)
*
|
2003-10-10 |
2011-04-07 |
Synthon B.V. |
Solid-state montelukast
|
US20050196439A1
(en)
*
|
2003-10-24 |
2005-09-08 |
J. Rettenmaier & Soehne Gmbh + Co. Kg |
Process for co-spray drying agents with dry silicified MCC
|
JP2005232260A
(ja)
*
|
2004-02-18 |
2005-09-02 |
Asahi Kasei Chemicals Corp |
セルロース無機化合物多孔質複合粒子
|
DE602004001969T2
(de)
*
|
2004-02-20 |
2007-03-15 |
Mattern, Udo |
Orale pharmazeutische Zusammensetzung und Verfahren zu ihrer Herstellung
|
MY142989A
(en)
*
|
2004-03-10 |
2011-02-14 |
Bayer Schering Pharma Ag |
Stabilised supersaturated solids of lipophilic drugs
|
US20070196471A1
(en)
*
|
2004-04-02 |
2007-08-23 |
Thosar Shilpa S |
Micronized Eplerenone Compositions
|
US7829716B2
(en)
|
2004-04-30 |
2010-11-09 |
Synthon Pharmaceuticals, Inc. |
Process for making montelukast and intermediates therefor
|
US7501517B2
(en)
*
|
2004-04-30 |
2009-03-10 |
Synthon Ip, Inc. |
Process for making montelukast and intermediates therefor
|
WO2006002255A2
(en)
*
|
2004-06-23 |
2006-01-05 |
Dr. Reddy's Laboratories Ltd. |
A pharmaceutical formulation of balaglitazone
|
EP1765296A2
(de)
*
|
2004-06-30 |
2007-03-28 |
Albemarle Corporation |
Granulat mit hohem ibuprofen-gehalt und seine herstellung und verwendung
|
ATE424814T1
(de)
*
|
2004-07-01 |
2009-03-15 |
Lek Pharmaceuticals |
Schnell zerfallende im mund dispergierbare zusammensetzung mit nicht-filamentösen mitverarbeiteten polyol-teilchen und verkieselter mikrokristalliner cellulose
|
JP2008507362A
(ja)
*
|
2004-07-22 |
2008-03-13 |
ヘモ ナノサイエンス リミテッド ライアビリティ カンパニー |
過剰な出血を処置するための組成物および方法
|
CN101262852A
(zh)
*
|
2004-12-13 |
2008-09-10 |
麦克内尔-Ppc股份有限公司 |
稳定活性药物成分的组合物和方法
|
TWI323741B
(en)
*
|
2004-12-16 |
2010-04-21 |
K C Tech Co Ltd |
Abrasive particles, polishing slurry, and producing method thereof
|
KR100641348B1
(ko)
*
|
2005-06-03 |
2006-11-03 |
주식회사 케이씨텍 |
Cmp용 슬러리와 이의 제조 방법 및 기판의 연마 방법
|
US20070036859A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Perry Ronald L |
Sustained release antihistamine and decongestant composition
|
WO2007020079A2
(en)
*
|
2005-08-17 |
2007-02-22 |
Synthon B.V. |
Orally disintegratable simvastatin tablets
|
US20080058282A1
(en)
|
2005-08-30 |
2008-03-06 |
Fallon Joan M |
Use of lactulose in the treatment of autism
|
US20070116695A1
(en)
*
|
2005-09-21 |
2007-05-24 |
Fallon Joan M |
Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
EP2404919B1
(de)
|
2005-11-08 |
2013-08-21 |
Vertex Pharmaceuticals Incorporated |
Heterozyklische Verbindung zur Verwendung als Modulator von ATP-bindenden Kassettentransportern
|
US8440695B2
(en)
*
|
2005-11-09 |
2013-05-14 |
St Jude Children's Research Hospital |
Use of chloroquine to treat metabolic syndrome
|
US7811604B1
(en)
|
2005-11-14 |
2010-10-12 |
Barr Laboratories, Inc. |
Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
|
AR057909A1
(es)
*
|
2005-11-18 |
2007-12-26 |
Synthon Bv |
Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
|
DE102005061965A1
(de)
*
|
2005-12-23 |
2007-07-05 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Oxidische Agglomeratpartikel, Verfahren zur Herstellung von Nanokompositen sowie deren Verwendung
|
EP1996552A1
(de)
*
|
2006-03-17 |
2008-12-03 |
Synthon B.V. |
Montelukast-amantadin-salz
|
MY149923A
(en)
*
|
2006-03-24 |
2013-10-31 |
Kowa Co |
Oral fast-disintegrating tablet
|
US20100227916A1
(en)
*
|
2006-05-19 |
2010-09-09 |
Somaxon Pharmaceuticals, Inc |
N-desmethyl-doxepin and methods of using the same to treat sleep disorders
|
WO2007136845A2
(en)
|
2006-05-19 |
2007-11-29 |
Somaxon Pharmaceuticals, Inc. |
Low-dose doxepin for treatment of sleep disorders in elderly patients
|
US20100179215A1
(en)
*
|
2006-05-19 |
2010-07-15 |
Somaxon Pharmaceuticals, Inc. |
Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
|
CA2687118A1
(en)
|
2006-05-19 |
2007-12-13 |
Somaxon Pharmaceuticals, Inc. |
Methods of using low-dose doxepin for the improvement of sleep
|
US20100179214A1
(en)
|
2006-05-19 |
2010-07-15 |
Somaxon Pharmaceuticals, Inc. |
Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
|
US20070292508A1
(en)
*
|
2006-06-05 |
2007-12-20 |
Balchem Corporation |
Orally disintegrating dosage forms
|
US20070281016A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Endo Pharmaceuticals Inc., A Delaware Corporation |
Sustained release oxycodone composition with acrylic polymer and surfactant
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
US8158156B2
(en)
|
2006-06-19 |
2012-04-17 |
Alpharma Pharmaceuticals, Llc |
Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
|
GB0612809D0
(en)
*
|
2006-06-28 |
2006-08-09 |
Univ Sunderland |
Formulation
|
CA2693992C
(en)
*
|
2006-07-20 |
2017-01-31 |
Somaxon Pharmaceuticals, Inc. |
Methods of improving the pharmacokinetics of doxepin
|
WO2008018556A1
(en)
*
|
2006-08-09 |
2008-02-14 |
Mitsubishi Tanabe Pharma Corporation |
Tablet
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US8124598B2
(en)
*
|
2006-09-14 |
2012-02-28 |
Sharon Sageman |
7-keto DHEA for psychiatric use
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
US9138414B1
(en)
|
2006-09-15 |
2015-09-22 |
Delavau Llc |
Calcium supplement having enhanced absorption
|
US20080081069A1
(en)
*
|
2006-09-28 |
2008-04-03 |
Lupin Limited |
Novel controlled release formulations of divalproex sodium
|
US20080182890A1
(en)
*
|
2006-10-04 |
2008-07-31 |
Somaxon Pharmaceuticals, Inc. |
Methods of using low-dose doxepin for the improvement of sleep
|
ES2524556T3
(es)
|
2006-10-09 |
2014-12-10 |
Charleston Laboratories, Inc. |
Composiciones farmacéuticas
|
AU2007322269A1
(en)
*
|
2006-10-11 |
2008-05-29 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical compositions
|
WO2008051513A2
(en)
*
|
2006-10-23 |
2008-05-02 |
Allan Pronovost |
Compositions and methods for treating lacerations, abrasions, avulsions, burns, ulcers, and cases of excessive bleeding
|
WO2008052139A2
(en)
|
2006-10-25 |
2008-05-02 |
Somaxon Pharmaceuticals, Inc. |
Ultra low dose doxepin and methods of using the same to treat sleep disorders
|
DE602007011792D1
(de)
*
|
2006-10-27 |
2011-02-17 |
Fmc Corp |
Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen
|
JP2010508353A
(ja)
*
|
2006-10-31 |
2010-03-18 |
アキリオン ファーマシューティカルズ,インコーポレーテッド |
エルブシタビン薬学的組成物
|
WO2008070795A2
(en)
|
2006-12-06 |
2008-06-12 |
Somaxon Pharmaceuticals, Inc. |
Combination therapy using low-dose doxepin for the improvement of sleep
|
CA2671728C
(en)
*
|
2006-12-20 |
2015-05-26 |
Genpharm Ulc |
Pharmaceutical composition comprising a hot-melt granulated lubricant
|
US20080167325A1
(en)
*
|
2006-12-27 |
2008-07-10 |
Bs Praveen Kumar |
Valacyclovir compositions
|
PT2487163T
(pt)
|
2007-02-23 |
2016-11-21 |
Gilead Sciences Inc |
Moduladores de propriedades farmacocinéticas de agentes terapêuticos
|
CA2721133C
(en)
*
|
2007-04-13 |
2018-11-06 |
Somaxon Pharmaceuticals, Inc. |
Low-dose doxepin formulations and methods of making and using the same
|
RU2472493C2
(ru)
*
|
2007-05-08 |
2013-01-20 |
Геркулес Инкорпорейтед |
Композиция прочной быстро распадающейся таблетки
|
EP1997480A1
(de)
*
|
2007-06-01 |
2008-12-03 |
The Jordanian Pharmaceutical Manufacturing Co. |
Mineralfaser-Feststoff-Dispersion, Verfahren zu ihrer Herstellung und ihre Verwendung als Hilfe bei der pharmazeutischen Tablettierung
|
US20100160274A1
(en)
*
|
2007-09-07 |
2010-06-24 |
Sharon Sageman |
7-KETO DHEA for Psychiatric Use
|
DE102007045686A1
(de)
*
|
2007-09-24 |
2009-04-02 |
J. Rettenmaier & Söhne Gmbh + Co. Kg |
Verfahren zur Herstellung frei fließender, pulverförmiger Extrakte mit Hilfe der Wirbelschicht Trocknung
|
US9198687B2
(en)
*
|
2007-10-17 |
2015-12-01 |
Covidien Lp |
Acute stroke revascularization/recanalization systems processes and products thereby
|
PL2225230T3
(pl)
|
2007-12-07 |
2017-08-31 |
Vertex Pharmaceuticals Incorporated |
Stałe postacie kwasu 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-ilo)cyklopropanokarboksyamido)-3-metylopirydyn-2-ylo)benzoesowego
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
WO2009079521A1
(en)
*
|
2007-12-17 |
2009-06-25 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
AU2008346870A1
(en)
*
|
2007-12-17 |
2009-07-16 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
WO2009080061A1
(en)
*
|
2007-12-20 |
2009-07-02 |
Pharmathen S.A. |
Sustained-release pharmaceutical formulation containing an antimuscarinic agent and a wetting agent as well as a process for the preparation thereof
|
CA2905541C
(en)
|
2008-01-09 |
2020-02-11 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
|
EP2098119A1
(de)
|
2008-02-15 |
2009-09-09 |
Sara Lee/DE N.V. |
Insektizidzusammensetzung mit anhaltender Freisetzung
|
CA2720108C
(en)
|
2008-03-11 |
2016-06-07 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
US8658163B2
(en)
|
2008-03-13 |
2014-02-25 |
Curemark Llc |
Compositions and use thereof for treating symptoms of preeclampsia
|
EP2100599A1
(de)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
|
EP2100598A1
(de)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
|
US8084025B2
(en)
|
2008-04-18 |
2011-12-27 |
Curemark Llc |
Method for the treatment of the symptoms of drug and alcohol addiction
|
CN102046602A
(zh)
*
|
2008-04-25 |
2011-05-04 |
斯索恩有限公司 |
制备孟鲁司特中间体的方法
|
MX2010011963A
(es)
|
2008-05-02 |
2010-12-06 |
Gilead Sciences Inc |
Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico.
|
US9320780B2
(en)
|
2008-06-26 |
2016-04-26 |
Curemark Llc |
Methods and compositions for the treatment of symptoms of Williams Syndrome
|
ES2732453T3
(es)
|
2008-07-01 |
2019-11-22 |
Curemark Llc |
Métodos y composiciones para el tratamiento de síntomas de trastornos neurológicos y de salud mental
|
US10776453B2
(en)
|
2008-08-04 |
2020-09-15 |
Galenagen, Llc |
Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
|
CA2732131A1
(en)
|
2008-08-06 |
2010-02-11 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating psychiatric disorders
|
US20100092447A1
(en)
|
2008-10-03 |
2010-04-15 |
Fallon Joan M |
Methods and compositions for the treatment of symptoms of prion diseases
|
CA2740017A1
(en)
*
|
2008-10-20 |
2010-04-29 |
Xenoport, Inc. |
Methods of synthesizing a levodopa ester prodrug
|
US8399513B2
(en)
|
2008-10-20 |
2013-03-19 |
Xenoport, Inc. |
Levodopa prodrug mesylate hydrate
|
EP2373693A4
(de)
|
2009-01-06 |
2012-04-25 |
Curelon Llc |
Zusammensetzungen und verfahren zur behandlung bzw. prävention von mundinfektionen durch e.coli
|
GB2480772B
(en)
|
2009-01-06 |
2013-10-16 |
Curelon Llc |
Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus
|
WO2010109019A1
(en)
|
2009-03-26 |
2010-09-30 |
Royal College Of Surgeons In Ireland |
Orodispersible tablets
|
US9056050B2
(en)
|
2009-04-13 |
2015-06-16 |
Curemark Llc |
Enzyme delivery systems and methods of preparation and use
|
US20100285164A1
(en)
*
|
2009-05-11 |
2010-11-11 |
Jrs Pharma |
Orally Disintegrating Excipient
|
EP2253306A1
(de)
|
2009-05-18 |
2010-11-24 |
Royal College of Surgeons in Ireland |
Orodispersible Dosierungsformen mit Festarzneimitteldispersionen
|
WO2011006012A1
(en)
|
2009-07-08 |
2011-01-13 |
Charleston Laboratories Inc. |
Pharmaceutical compositions
|
CA2769177A1
(en)
*
|
2009-07-28 |
2011-02-03 |
Takeda Pharmaceutical Company Limited |
Tablet
|
US20120214820A1
(en)
|
2009-09-15 |
2012-08-23 |
Ratiopharm Gmbh |
Orally disintegrating pharmaceutical dosage form containing aripiprazole
|
US9511125B2
(en)
|
2009-10-21 |
2016-12-06 |
Curemark Llc |
Methods and compositions for the treatment of influenza
|
TWI461213B
(zh)
*
|
2009-11-05 |
2014-11-21 |
Fmc Corp |
作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
|
WO2011056240A2
(en)
*
|
2009-11-09 |
2011-05-12 |
Xenoport, Inc. |
Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
|
US20110144211A1
(en)
*
|
2009-12-11 |
2011-06-16 |
Lars Hermann |
Use of microcrystalline cellulose for interfering with the extraction of ephedrine
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
US9198861B2
(en)
|
2009-12-22 |
2015-12-01 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
NZ602838A
(en)
|
2010-04-07 |
2015-06-26 |
Vertex Pharma |
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
|
WO2011143120A1
(en)
|
2010-05-11 |
2011-11-17 |
Cima Labs Inc. |
Alcoholres i stant metoprolol - containing extended - release oral dosage forms
|
HU1000278D0
(en)
*
|
2010-05-28 |
2010-07-28 |
Egis Gyogyszergyar Nyilvanosan |
Novel pharmaceutical use uf silicic acid
|
WO2012002253A1
(ja)
|
2010-06-29 |
2012-01-05 |
旭化成ケミカルズ株式会社 |
セルロースと無機化合物を含む複合粒子
|
RU2013136350A
(ru)
|
2011-02-02 |
2015-03-27 |
АЛФАРМА ФАРМАСЬЮТИКЭЛЗ, ЭлЭлСи |
Фармацевтическая композиция, содержащая опиоидный агонист и секвестрированный антагонист
|
DE102011010437A1
(de)
*
|
2011-02-04 |
2012-08-09 |
J. Rettenmaier & Söhne Gmbh + Co. Kg |
Tablettierhilfsmittel
|
US8992987B2
(en)
|
2011-04-06 |
2015-03-31 |
Dow Global Technologies Llc |
Polysaccharide derivatives and dosage forms
|
EP2510928A1
(de)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
|
WO2012145651A2
(en)
|
2011-04-21 |
2012-10-26 |
Curemark, Llc |
Compounds for the treatment of neuropsychiatric disorders
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
US8741885B1
(en)
|
2011-05-17 |
2014-06-03 |
Mallinckrodt Llc |
Gastric retentive extended release pharmaceutical compositions
|
US8658631B1
(en)
|
2011-05-17 |
2014-02-25 |
Mallinckrodt Llc |
Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
HUE025350T2
(en)
*
|
2011-07-19 |
2016-02-29 |
Pantarhei Bioscience Bv |
Tablets containing dehydroepiandrosterone (DHEA)
|
US10350278B2
(en)
|
2012-05-30 |
2019-07-16 |
Curemark, Llc |
Methods of treating Celiac disease
|
WO2014165246A1
(en)
|
2013-03-12 |
2014-10-09 |
Hercules Incorporated |
Coprocessed silica coated polymer composition
|
US9675587B2
(en)
|
2013-03-14 |
2017-06-13 |
Allergan Holdings Unlimited Company |
Opioid receptor modulator dosage formulations
|
CO7150300A1
(es)
*
|
2013-06-27 |
2014-12-29 |
Univ Antioquia |
Producción de un nuevo excipiente celulósico aglomerado multipropósito
|
MX2016006118A
(es)
|
2013-11-12 |
2016-07-21 |
Vertex Pharma |
Proceso para preparar composiciones farmaceuticas para el tratamiento de enfermedades mediadas por regulador de la conductancia transmembrana de la fibrosis quistica (cftr).
|
WO2015073736A1
(en)
|
2013-11-13 |
2015-05-21 |
Arbor Pharmaceuticals, Llc |
Methods and compositions for treating adhd
|
EP2907498A1
(de)
*
|
2014-02-13 |
2015-08-19 |
Induchem Ag |
Abschälende Celluloseperlen und ihre Verwendung in der Kosmetik
|
KR101665970B1
(ko)
*
|
2015-01-06 |
2016-10-13 |
주식회사이-글벳 |
케토코나졸 정제의 제조방법
|
CN104771761A
(zh)
*
|
2015-03-19 |
2015-07-15 |
深圳国源国药有限公司 |
一种创新药用辅料硅化微晶纤维素及其制备方法
|
WO2016201119A1
(en)
*
|
2015-06-09 |
2016-12-15 |
J. Rettenmaier & Söhne Gmbh + Co Kg |
Excipient and oral solid dosage forms for oily drugs
|
US10166185B2
(en)
|
2015-06-09 |
2019-01-01 |
J. Rettenmaier & Söhne Gmbh + Co Kg |
Excipient and oral solid dosage forms for oily drugs
|
WO2017004526A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Louisville Research Foundation, Inc. |
EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER
|
CA2937365C
(en)
|
2016-03-29 |
2018-09-18 |
F. Hoffmann-La Roche Ag |
Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
|
US10751288B2
(en)
|
2016-08-23 |
2020-08-25 |
New Jersey Institute Of Technology |
Dry processed surface coated engineering excipients
|
CN107583055A
(zh)
*
|
2017-09-01 |
2018-01-16 |
山东聊城阿华制药股份有限公司 |
一种微晶纤维素‑二氧化硅预混剂制备方法
|
WO2021076218A1
(en)
*
|
2019-10-18 |
2021-04-22 |
Weinberg Assa |
Methods for prevention and treatment of fibromyalgia by contact vasodilators
|
US11541009B2
(en)
|
2020-09-10 |
2023-01-03 |
Curemark, Llc |
Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
|
US11925707B2
(en)
|
2021-03-15 |
2024-03-12 |
Jrs Pharma Gmbh & Co. Kg |
Co-processed lubricant:MCG for tablets
|
CN113968584B
(zh)
*
|
2021-10-28 |
2022-05-27 |
金三江(肇庆)硅材料股份有限公司 |
一种中空球形二氧化硅及其制备方法
|